ATAGI statement on meningococcal ACWY vaccine (Nimenrix®) for adolescents

This resource provides advice on the introduction of meningococcal ACWY vaccine (Nimenrix®) for adolescents through the National Immunisation Program (NIP).

Downloads

ATAGI statement on meningococcal ACWY vaccine (Nimenrix®) for adolescents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Standard
Audience:
Health sector
Language:
English
Description:

The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice on the introduction of meningococcal ACWY vaccine (Nimenrix®) for adolescents through the National Immunisation Program (NIP).

It includes information about:

  • recommendations for the use of meningococcal ACWY vaccine
  • safety and effectiveness of the meningococcal ACWY vaccine
  • eligibility for NIP funded meningococcal ACWY vaccine
  • contraindications for the meningococcal ACWY vaccine
  • meningococcal vaccines available for use in Australia.
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.